Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.

Budecort 0.5mg Respules

Generic: Budesonideby Cipla Limited

Buy Budecort 0.5mg Respules (Budesonide) online | SafeRxPills

Strength

Select pack size

1
Free shipping over $149
Free reshipment if lost
Discreet packaging
WHO-GMP certified
Secure checkout

Similar medicines

View all
Buy Budecort 200 Inhaler (Budesonide) online | SafeRxPills

Budecort 200 Inhaler

$27.00View
Buy Budecort 400 Rotacaps (Budesonide) online | SafeRxPills

Budecort 400 Rotacaps

$17.50View
Buy Budesal 0.5 Respules (Budesonide/Levalbuterol) online | SafeRxPills

Budesal 0.5 Respules

$56.00View
Buy Foracort 0.5mg Respules (Budesonide/Formoterol) online | SafeRxPills

Foracort 0.5mg Respules

$45.00View

About Budecort 0.5mg Respules

Budecort 0.5mg Respules are single-dose plastic ampoules of budesonide nebuliser suspension made in India by Cipla. Indian pharmacy listings give each respule as budesonide 0.5 mg in 2 mL, sold in packets of 5. Budesonide is an inhaled corticosteroid: a preventer that calms inflammation in the airways when it is used every day, breathed in as a mist through a jet nebuliser. We sell packs of 30, 60 and 90 respules, from $1.02 a respule in the 60 pack.

This page covers how Budecort compares with Pulmicort Respules and US generic budesonide, how many respules a day the US and UK labels add up to, how to use it with a nebuliser, side effects including growth in children, when to get urgent help, who should not use it and the price per respule. Clinical figures come from the US prescribing information for Pulmicort Respules and the UK Pulmicort Respules product information, listed at the end. We have not found a published study comparing Budecort respules with Pulmicort Respules.

Budecort is not a reliever. The US label says it is "NOT indicated for the relief of acute bronchospasm" and that it "is not a bronchodilator". Anyone using it needs a fast-acting reliever, such as salbutamol, for sudden symptoms.

Budecort 0.5mg Respules at a glance

Active ingredientBudesonide 0.5 mg per 2 mL respule, as listed by Indian pharmacies
Brand and makerBudecort, by Cipla Limited, India
FormNebuliser suspension in single-dose respules; needs a jet nebuliser and compressor (not an ultrasonic nebuliser)
Regulatory statusBudesonide nebuliser suspension is licensed in the US, UK, Canada and Australia (Pulmicort Respules in the US, UK and Australia, Pulmicort Nebuamp in Canada, and generics in the US and Canada). This Indian Budecort pack is not registered with the FDA, MHRA, TGA or Health Canada.
Usual dose from the labelsUS (children 12 months to 8 years): 0.25 mg to 1 mg a day in total, once daily or split into two doses, set by previous treatment. UK maintenance: adults and children 12 and over 0.5 to 1 mg twice a day; children 3 months to 12 years 0.25 to 0.5 mg twice a day.
Time to benefitUS label: improvement can occur within 2 to 8 days, and maximum benefit may take 4 to 6 weeks
Packs30, 60 and 90 respules
Price per respule$1.27 (30 pack), $1.02 (60 pack) and $1.03 (90 pack), before shipping
Delivery7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149

Price per respule

Prices below are as of October 2026. The pack selector above always shows the current price.

PackPricePer respuleShippingPer respule with shippingLasts at 1 a dayLasts at 2 a day
30 respules$38$1.27$25$2.1030 days15 days
60 respules$61$1.02$25$1.4360 days30 days
90 respules$93$1.03$25$1.3190 days45 days

One 0.5 mg respule a day is 0.5 mg once daily; two a day is 0.5 mg twice daily, which is 1 mg a day, the highest dose in the US label. The last two columns are our own arithmetic, not label figures. At the UK adult maintenance dose of 0.5 to 1 mg twice a day you would use 2 to 4 respules a day, so a 90 pack would last about 22 to 45 days.

All three packs are under the $149 free shipping threshold. Before shipping the 60 pack is slightly cheaper per respule than the 90 pack ($1.02 against $1.03); the 90 pack works out cheapest only once the flat $25 is spread over more respules. Reaching $149 with this product alone takes at least 120 respules (four 30 packs, $152), which is about four months at one a day. Do not buy more than your prescription covers: check the expiry date when your order arrives.

Compared with Pulmicort Respules and US generics

Budecort 0.5mg RespulesPulmicort Respules 0.5 mg/2 mL (US)US generic budesonide inhalation suspension 0.5 mg/2 mL
MakerCipla, IndiaAstraZeneca (made in Sweden)Several makers, including Teva, Amneal and Cipla USA
Dose and fill0.5 mg in 2 mL (Indian listings)0.5 mg in 2 mL0.5 mg in 2 mL
FDA approvedNoYesYes
Price per respule (ours) or US pharmacy cost$1.02 to $1.27 before shipping; $1.31 to $2.10 with shippingAbout $9.82 pharmacy acquisition cost (NADAC)About $1.25 pharmacy acquisition cost (NADAC)

NADAC is what US pharmacies pay, not a retail price. The figures above are the per mL rates in the NADAC file effective 21 October 2026 ($0.62672 per mL for 15 generic NDCs and $4.90775 per mL for Pulmicort Respules) times the 2 mL fill. Before shipping our price per respule is close to what a US pharmacy pays for the generic; with shipping, every pack costs more per respule than that. If you are in the US and have a prescription or insurance, compare your copay and local cash prices for the generic before you order from abroad.

Cipla also sells an FDA-approved generic budesonide inhalation suspension in the US through Cipla USA; its US label says it is made by Cipla in Goa or Indore, India, or at Cipla (Jiangsu) in China. Budecort is Cipla's Indian brand. We have not seen evidence that Budecort and the US Cipla product share the same formulation or factory, so do not treat them as the same registered product.

Which strength to choose

The US label sets the dose by previous asthma treatment for children aged 12 months to 8 years. The UK label covers adults and children from 3 months. This table turns each labelled dose into 0.5 mg respules a day (our arithmetic):

Label doseWhich labelBudecort 0.5mg respules
0.25 mg once daily (a possible start in children with symptoms not responding to non-steroid treatment)USHalf a respule. The US label has a 0.25 mg respule for this; the UK label allows using 1 mL of a 0.5 mg respule, but the rest "is not sterile and should be discarded immediately"
0.5 mg a day, once daily or as 0.25 mg twice daily (start after bronchodilators alone or after inhaled steroids)US1 respule once a day
1 mg a day, as 0.5 mg twice daily or 1 mg once daily (start after steroid tablets; highest US dose)US2 respules a day, or one Budecort 1mg respule once a day
0.25 to 0.5 mg twice daily (maintenance, children 3 months to 12 years)UKHalf to 1 respule twice a day
0.5 to 1 mg twice daily (maintenance, adults and children 12 and over)UK1 to 2 respules twice a day
0.5 to 1 mg twice daily (starting treatment, severe periods, or coming off steroid tablets, children 3 months to 12 years)UK1 to 2 respules twice a day
Usually 1 to 2 mg twice daily (starting treatment, severe periods, or coming off steroid tablets, adults and children 12 and over; "In very severe cases the dosage may be further increased")UK2 to 4 respules twice a day; Budecort 1mg halves the number

The US label says the highest recommended dose is 1 mg a day in total, and 0.5 mg a day for children who were previously on bronchodilators alone. The UK label says the highest dose for children under 12, 2 mg a day, "should only be considered in children with severe asthma and during limited periods". Both labels say to step down to the lowest dose that keeps asthma controlled. The dose, and any change to it, is your doctor's decision. Budecort 1mg Respules are in our range as well. Other budesonide forms: the Budecort 200 Inhaler and Budecort 400 Rotacaps; combination respules: Budesal 0.5 Respules (budesonide with levosalbutamol) and Foracort 0.5mg Respules (budesonide with formoterol).

How to use Budecort respules with a nebuliser

These steps follow the US and UK Pulmicort Respules instructions. Follow the Cipla leaflet in the pack and your nebuliser maker's instructions as well.

  1. Use a jet nebuliser connected to an air compressor, with a mouthpiece or a face mask that fits well. The US and UK labels say ultrasonic nebulisers are not suitable. The UK label gives an air flow of 6 to 8 litres a minute and a fill volume of 2 to 4 mL.
  2. Break one respule off the strip and keep the rest in their packaging, away from light.
  3. Shake the respule gently in a circular motion. The UK label describes the suspension as white to off-white.
  4. Hold it upright and twist off the top. Squeeze all of the contents slowly into the nebuliser cup and throw the empty respule away.
  5. Breathe in the mist calmly and deeply until it stops coming out. The US label says the mean nebulising time in its test system was 5 minutes or less; the UK leaflet says the time depends on the equipment you use.
  6. Rinse your mouth with water and spit it out. If you used a face mask, wash your face too: the UK label says this prevents facial skin irritation.
  7. Wash the nebuliser cup and mouthpiece or mask after every use, as the nebuliser maker describes.

Mixing with other nebuliser medicines: the labels disagree. The US label says the effects of mixing "have not been adequately assessed" and that it should be given separately, and the US patient leaflet says "Do not mix" it with other nebuliser medicines. The UK label allows mixing with 0.9% saline and with nebuliser solutions of terbutaline, salbutamol, fenoterol, acetylcysteine, sodium cromoglycate or ipratropium bromide, used within 30 minutes. Levosalbutamol (Levolin) is not on the UK list. Ask your doctor before putting anything else in the cup.

How much reaches the lungs depends on the nebuliser. In the US label's test system, about 17% of the labelled dose was delivered at the mouthpiece. The US trials used a Pari LC Jet Plus nebuliser with a Pari Master compressor, and the label says results with other nebulisers and compressors have not been established.

Use it every day at regular times, even when there are no symptoms. If you miss a dose, the US and UK leaflets say skip it and take the next dose as usual. Do not stop it without talking to your doctor: the US label says symptoms may come back.

Storage: the US label says store the respules upright at 20 to 25°C, protected from light, and use them within 2 weeks of opening the foil envelope; its patient leaflet adds "Do not refrigerate or freeze". The UK label says do not store above 30°C, protect from freezing, and use within 3 months of opening the foil envelope. Indian listings for Budecort say store below 30°C (Tata 1mg, Truemeds) or at 20 to 25°C and away from freezing (Apollo). We have not confirmed whether the Indian packet comes in a foil envelope or what its opened-pack period is: follow the Cipla leaflet, and if it gives none, using opened respules within 2 weeks (the stricter US rule) is our cautious suggestion. Our parcels are not temperature controlled; if respules arrive frozen, or the suspension will not mix when shaken, contact us before using them. Our guide to respules, inhalers and Rotacaps explains when a nebuliser is worth it and when an inhaler with a spacer works as well.

Groups who need extra care

  • Children 12 months to 8 years: the only age group in the US indication. The US label says to check children's growth routinely (for example with a stadiometer) and use the lowest dose that works.
  • Babies under 12 months: the US label says safety and effectiveness in children 6 to 12 months "has been evaluated but not established". The UK label doses children from 3 months.
  • Adults and children over 8: not covered by the US label (the US leaflet says it is not known whether it is safe or effective in children older than 8 years); the UK label includes them, for asthma "in patients where use of a pressurised inhaler or dry powder formulation is unsatisfactory or inappropriate".
  • Coming off steroid tablets: the US label warns that deaths due to adrenal insufficiency have occurred during and after transfer from steroid tablets to inhaled steroids. Tablets must be reduced slowly under a doctor's care, and the label says people who have recently stopped them should carry a card saying they may need extra steroids during stress or a severe attack.
  • Liver disease: budesonide is cleared mainly by the liver, so the US label says people with liver disease should be closely monitored.
  • Weak bones, or risk factors for them (long immobility, a family history of osteoporosis, poor nutrition, long-term anticonvulsants or steroids): the US label says to monitor and treat to established standards.
  • Eye problems: glaucoma, raised eye pressure and cataracts have been reported with long-term inhaled steroids. The US label calls for close monitoring with a change in vision or a history of these; the UK label says a person with blurred vision or other visual disturbance should be considered for referral to an eye specialist.
  • COPD: neither the US nor the UK label lists COPD as an indication, though some Indian listings mention it. The UK label warns of more pneumonia, including pneumonia needing hospital care, in people with COPD on inhaled steroids.
  • Pregnancy: the US label says studies of pregnant women have not shown that inhaled budesonide increases the risk of abnormalities; in Swedish registry data, malformations were recorded in 3.8% of 2,014 infants exposed in early pregnancy against 3.5% in the general population. It also says that in women with poorly or moderately controlled asthma there is an increased risk of pre-eclampsia in the mother and of prematurity, low birth weight and small for gestational age in the baby. The UK leaflet says if you become pregnant, do not stop it but talk to your doctor immediately.
  • Breastfeeding: budesonide passes into breast milk. The US label estimates the infant gets about 0.3% to 1% of the mother's inhaled dose (dry powder inhaler data) and says to weigh benefits and risks; the UK label says Pulmicort Respules "can be used during breast-feeding".

Medicines that interact:

  • The US label says strong CYP3A4 inhibitors may inhibit the breakdown of budesonide and increase the amount that reaches the body, so adverse effects related to this may occur. The US label advises caution with ketoconazole, ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir and telithromycin. The UK label says the combination with potent CYP3A inhibitors (for example itraconazole, ketoconazole, HIV protease inhibitors and cobicistat-containing products) "should be avoided unless the benefit outweighs the increased risk"; limited data for high-dose inhaled budesonide indicate that marked increases in blood levels (on average four-fold) may occur with itraconazole 200 mg once daily.
  • Other corticosteroids, anti-seizure medicines (anticonvulsants) and medicines that suppress the immune system: the US leaflet asks you to tell your doctor especially about these.

Side effects

In three 12 week placebo-controlled US trials in 945 children aged 12 months to 8 years, these adverse events were reported in 3% or more of children in at least one Pulmicort Respules group, and more often than with placebo in that group. They were counted whether or not they were caused by the medicine, and the label says the incidence and nature of adverse events were comparable to placebo.

Adverse eventPlacebo (227)0.25 mg a day (178)0.5 mg a day (223)1 mg a day (317)
Respiratory infection36%34%35%38%
Rhinitis (runny or blocked nose)9%7%11%12%
Coughing5%5%9%8%
Middle ear infection (otitis media)11%12%11%9%
Viral infection3%4%5%3%
Thrush (moniliasis)2%4%3%4%
Gastroenteritis4%5%5%5%
Vomiting3%2%4%4%
Diarrhoea2%4%4%2%
Abdominal pain2%3%2%3%
Ear infection4%2%4%5%
Nosebleed1%2%4%3%
Conjunctivitis2%under 1%4%2%
Rash3%under 1%4%2%

Source: US label Table 1. The UK label lists thrush in the mouth and throat, cough, hoarseness and throat irritation as common, and pneumonia as common in people with COPD. Uncommon effects include anxiety, depression, tremor, cataract, blurred vision and muscle spasm. Rare effects include allergic reactions, bruising, sleep problems, aggression and behaviour changes (mainly in children), and signs of too much steroid in the body such as adrenal suppression and slowed growth. Rinsing the mouth after each dose lowers the risk of thrush.

Growth in children. The US label says inhaled steroids may slow growth in children: in controlled studies the mean reduction in growth velocity was about 1 cm a year (range 0.3 to 1.8 cm), and appears to be related to dose and duration of exposure. In a 12 week study in 141 babies 6 to 12 months old (US label 8.4), average growth was 3.7 cm on placebo, 3.5 cm on 0.5 mg and 3.1 cm on 1 mg a day. The UK label reports one study in which children given high-dose budesonide (400 micrograms a day by dry powder inhaler) for up to 6 years, without stepping down to the lowest effective dose, were on average 1.2 cm shorter as adults than those given placebo. Both labels say to check children's height regularly and keep the dose as low as controls asthma.

Adrenal glands. In a study in 18 children aged 6 to 15 (US label 12.2), 1 mg a day (the highest recommended dose) did not significantly lower urinary cortisol, while 2 and 4 times that dose lowered it by 43% to 52%.

When to get urgent help

  • A severe asthma attack, or one that your reliever does not help: call emergency services now (911 in the US and Canada, 999 in the UK, 000 in Australia). Budecort will not relieve an attack. The US label tells patients to contact their doctor immediately if attacks do not respond to their usual reliever, and says oral steroids may be needed.
  • Wheezing that gets worse straight after a dose (paradoxical bronchospasm): use a fast-acting reliever now and stop Budecort. The US label says it should be treated immediately and Budecort replaced with another treatment.
  • Swelling of the face, lips, tongue or throat, trouble breathing or swallowing, rash, hives or severe itching: signs of an allergic reaction, including anaphylaxis. Stop Budecort (US label 5.3) and get medical help right away (US leaflet).
  • Tiredness, weakness, nausea and vomiting, or low blood pressure in someone who recently came off steroid tablets, especially during an illness, injury or surgery: possible adrenal insufficiency. The US label tells these patients to resume oral steroids (in large doses) immediately during stress or a severe attack and to contact their doctor.
  • A child on Budecort who has not had chickenpox or measles, or been vaccinated, and is exposed to either: the US label says to consult a doctor without delay.
  • Breathing getting worse, or often waking at night with asthma: the UK leaflet says contact your doctor immediately, because treatment may need to change. Needing your reliever more than usual, or finding it works less well, is also a reason to contact your doctor immediately (US label 17.3).

If too many respules are used: the US label says the potential for acute toxic effects after an overdose is low, and the UK label says acute overdose is not expected to be a clinical problem, but the UK leaflet says contact your doctor or pharmacist for advice. Using too much for a long time can cause steroid effects such as slowed growth (US label 10). Tell any doctor treating you what you use, how much and since when.

Who should not use Budecort 0.5mg Respules

Never use it (contraindications):

  • if you are allergic to budesonide or any ingredient of the respules (US and UK labels);
  • as the main treatment of status asthmaticus or other acute asthma attacks that need intensive treatment (US label).

Use with caution, if at all (US label 5.4):

  • active or quiescent tuberculosis of the lungs or airways; untreated fungal, bacterial, viral or parasitic infections throughout the body; or herpes infection of the eye. The UK label says special caution is necessary with active or quiescent lung tuberculosis and fungal or viral airway infections.

Avoid unless your doctor decides the benefit is worth it (UK label 4.5):

  • potent CYP3A inhibitors such as itraconazole, ketoconazole, HIV protease inhibitors and cobicistat-containing products (the US label advises caution; see above).

Talk to a doctor first:

  • if you are coming off steroid tablets, have liver disease, weak bones or eye problems, have COPD, are pregnant or breastfeeding, or the patient is under 12 months old (see above);
  • if you have not had chickenpox or measles or been vaccinated against them;
  • if you are planning surgery (US leaflet).

Croup is a hospital matter

One Indian listing (PharmEasy) says Budecort is used for croup. The UK label does license Pulmicort Respules for croup in infants and children, but only "in which hospitalisation is indicated", at 2 mg (four 0.5 mg respules, our arithmetic) given once or as two 1 mg doses 30 minutes apart, repeated every 12 hours for up to 36 hours. The US label does not include croup. A child with croup who is struggling to breathe, or has noisy breathing at rest, needs urgent medical care (our advice), not a parcel that takes 7 to 14 business days. Do not buy Budecort to keep at home for croup unless your child's doctor has told you to.

Prescription and legal status

Budesonide nebuliser suspension is a prescription medicine in the US ("Rx only", Pulmicort Respules and generics), the UK (Pulmicort Respules is listed as a prescription only medicine) and Canada (Pulmicort Nebuamp and Teva and Taro budesonide suspensions are marketed as prescription products in Health Canada's Drug Product Database). In Australia, Pulmicort Respules 500 micrograms/2 mL is listed on the PBS for severe chronic asthma (dispensed price A$87.37 for 30, general patient charge A$25.00), and it is a prescription only medicine (Schedule 4). Indian listings mark Budecort as prescription only (Tata 1mg, Truemeds and Apollo). This Indian Budecort pack is not registered with the FDA, the MHRA, the TGA or Health Canada, and in the US the FDA says personal importation of unapproved medicines is illegal in most circumstances. Asthma needs regular review by a doctor or nurse, including a written action plan. Check the rules where you live.

Buying genuine Budecort

The MHRA warns: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It also advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo." That warning covers this Indian Budecort pack. When your order arrives, check that the packets and respules name Cipla, Budecort and budesonide 0.5 mg in 2 mL, with a batch number and an expiry date, and that the respules are sealed. These checks cannot prove a product is genuine, because counterfeiters copy packaging. If asthma control gets worse after switching supply, see a doctor rather than taking extra doses. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.

Delivery

We ship Budecort 0.5mg Respules to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries, so order at least three weeks before your current supply runs out: a preventer works only if it is used every day. Shipping costs a flat $25 on orders under $149 and is free from $149. See our shipping page and refund policy.

Related guides

Sources

  • Pulmicort Respules (budesonide inhalation suspension), AstraZeneca, US prescribing information, patient information and instructions for use, DailyMed SPL version 23 of 20 November 2024, sections 1 to 8, 10 to 12, 14, 16 and 17. DailyMed
  • Budesonide inhalation suspension, Cipla USA, US prescribing information (revised 1/2024), DailyMed version of 12 June 2026. DailyMed
  • Pulmicort Respules 0.5mg, nebuliser suspension. UK summary of product characteristics (revised 22 March 2023) and patient leaflet, AstraZeneca UK, PL 17901/0160. emc
  • Health Canada Drug Product Database: Pulmicort Nebuamp, Teva-Budesonide and Taro-Budesonide inhalation suspensions, searched October 2026. Health Canada DPD
  • Pharmaceutical Benefits Scheme: budesonide 500 microgram/2 mL inhalation solution, item 2065Q, accessed October 2026. PBS
  • Australian Commission on Safety and Quality in Health Care, Medicine Finder: Pulmicort (consumer medicine information, September 2024), accessed October 2026. ACSQHC
  • Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), budesonide 0.5 mg/2 mL suspension and Pulmicort 0.5 mg/2 mL Respule, 2026 file, rates effective 21 October 2026. data.medicaid.gov
  • Tata 1mg, Truemeds, Apollo Pharmacy and PharmEasy. Budecort 0.5mg Respules (Cipla) listings, accessed October 2026. Tata 1mg
  • MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
  • US Food and Drug Administration. Personal Importation. FDA

This page is for information and is not medical advice. Budesonide is a prescription medicine; your doctor should set the dose and the asthma action plan, especially for a child.

Frequently asked questions

What is Budecort 0.5mg Respules?

Budecort 0.5mg Respules are single-dose ampoules of budesonide nebuliser suspension made by Cipla in India. Indian pharmacy listings give each respule as budesonide 0.5 mg in 2 mL, in packets of 5. Budesonide is an inhaled corticosteroid used every day through a jet nebuliser to prevent asthma symptoms. It is not a reliever. This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada.

Is Budecort the same as Pulmicort Respules?

It contains the same active ingredient at the same strength and fill, budesonide 0.5 mg in 2 mL, as Pulmicort Respules 0.5 mg. We have not found a published study comparing Budecort with Pulmicort Respules. Cipla also sells an FDA-approved generic budesonide inhalation suspension in the US, but we have not seen evidence that Budecort is the same formulation or comes from the same factory.

How much does Budecort 0.5mg cost per respule?

As of October 2026, $1.27 a respule in the 30 pack, $1.02 in the 60 pack and $1.03 in the 90 pack, before shipping. Shipping is $25 on orders under $149 and free from $149, which brings the cost to about $2.10, $1.43 and $1.31 a respule. US pharmacies pay about $1.25 for a generic 0.5 mg respule and about $9.82 for Pulmicort Respules (NADAC, October 2026). The pack selector shows the current price.

How do I use Budecort respules?

Use a jet nebuliser with an air compressor, not an ultrasonic nebuliser. Shake the respule gently, twist off the top, squeeze all of it into the nebuliser cup, then breathe the mist in calmly through a mouthpiece or well-fitting mask until it stops. Rinse your mouth with water afterwards, and wash your face if you used a mask. Ask your doctor before mixing it with other nebuliser medicines, as the US and UK labels disagree on mixing.

How many Budecort 0.5mg respules a day?

Your doctor sets the dose. Under the US label, for children 12 months to 8 years, the total is 0.25 mg to 1 mg a day: 0.5 mg a day is one respule, and 1 mg a day (the highest US dose) is two. The UK label gives adults and children 12 and over 0.5 to 1 mg twice a day for maintenance, which is 2 to 4 respules a day. Both labels say to use the lowest dose that controls asthma.

How long does Budecort take to work?

The US label says asthma control can improve within 2 to 8 days of starting, but maximum benefit may take 4 to 6 weeks. The UK leaflet says asthma may improve within 2 days and full effect can take up to 4 weeks. It must be used every day. It does not relieve an asthma attack: use a fast-acting reliever for that, and contact your doctor if symptoms do not improve.

Can adults use Budecort respules, and is it for croup?

The US label covers only children aged 12 months to 8 years. The UK label covers adults and children from 3 months where an inhaler or dry powder device is unsatisfactory or inappropriate. The UK label also licenses budesonide respules for croup, but only in children who need hospital care, at 2 mg. A child struggling to breathe with croup needs urgent medical care, not respules ordered online.

What are the side effects of Budecort respules?

The UK label lists thrush in the mouth and throat, cough, hoarseness and throat irritation as common. In the US trials in young children, adverse events such as respiratory infections, runny nose and ear infections were about as common as with placebo. Inhaled steroids may slow growth in children by about 1 cm a year on average in controlled studies (US label), so children's height should be checked regularly. Rinsing the mouth after each dose lowers the risk of thrush.

Who should not use Budecort 0.5mg Respules?

Do not use it if you are allergic to budesonide or any ingredient, or as the main treatment of a severe asthma attack (US label). The US label says use it with caution, if at all, with tuberculosis of the lungs, untreated infections throughout the body or herpes infection of the eye. Talk to a doctor first if coming off steroid tablets, with liver disease, weak bones, eye problems, COPD, pregnancy, or if you take ketoconazole, itraconazole, ritonavir or clarithromycin.

Do I need a prescription for Budecort?

Budesonide nebuliser suspension is prescription only in the US, UK and Canada, and in Australia Pulmicort Respules is a prescription only medicine (Schedule 4), listed on the PBS for severe chronic asthma. Indian pharmacies list Budecort as prescription only. This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada, and in the US the FDA says personal importation of unapproved medicines is illegal in most circumstances.

How long does delivery take?

Standard delivery takes 7 to 14 business days to the US, UK, Australia and Canada, in plain packaging with tracking. Shipping is a flat $25 on orders under $149 and free from $149. Because Budecort only works if it is used every day, order at least three weeks before your supply runs out.

Medical References

  1. 1.OpenFDA Drug Label (U.S. FDA)
  2. 2.ClinicalTrials.gov NCT03197818
  3. 3.ClinicalTrials.gov NCT04892732
  4. 4.ClinicalTrials.gov NCT00000575

Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA

Guide to AsthmaHow asthma medicines actually work: relievers, inhaled steroids, combination inhalers and leukotriene tablets, with the 2019 guideline change that ended reliever-only treatment.

Related articles

Customer Reviews

No reviews yet. Bought Budecort 0.5mg Respules? Tell other buyers how it went.